Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor ...
A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results